The global biosensors market size is expected to grow from USD 21.3 billion in 2019 to USD 40.5 billion by 2027, at a CAGR of 15.4%. The growth is likely to be driven by continuous technological advancements in biosensors ecosystem, increase in the use of biosensors for nonmedical applications, lucrative growth in POC diagnostics, and rise in demand for glucose monitoring systems.
Key Market Players
F. Hoffman-La Roche Ltd. (Switzerland), Medtronic Inc. (US), LifeScan Inc. (US), Universal Biosensors Inc. (Australia), Abbott Point of Care Inc. (US), DuPont (US), Sysmex Corporation (Japan), Pharmaco-Kinesis Corporation (PKC) (US), ACON Laboratories, Inc. (US), LifeSensors Inc. (US), Bio-Rad laboratories Inc. (US), Biacore (Sweden), Nova Biomedical Corp. (US), and Biosensors International Pte. Ltd. (US) are among the companies operating in the biosensors market.
Medtronic, Inc. (US) is a leading developer and manufacturer of medical devices, therapies, and services used for treating heart, spinal, neurological, vascular, and diabetic conditions. It operates in 4 business segments—Minimally Invasive Therapy Group, Cardiac and Vascular Group, Restorative Therapies Group, and Diabetes Group. The company offers a wide range of products and has operations in North America, APAC, and Europe. To increase production efficiency and gain a competition edge, Medtronic, Inc. adopts mergers and acquisitions as its growth strategy. For instance, in October 2015, Medtronic, Inc. (US) acquired Twelve, Inc. (US), a medical device company that develops transcatheter mitral valve replacement devices. It was acquired by Medtronic’s Coronary & Structural Heart division.
LifeScan Inc. (US) is a subsidiary of Johnson & Johnson, which accounted for a market share of 11%, in 2015. The company offers a comprehensive range of products in the field of medical diabetes. It manufactures and markets blood glucose monitoring solutions for hospitals and consumer use.
The company adopts product launches, agreements, and partnerships as its key growth strategies. For instance, in March 2016, the company signed an agreement with WellDoc Inc. (US) to integrate LifeScan’s OneTouch Verio Flex blood glucose monitoring system and OneTouch Reveal mobile application with WellDoc’s BlueStar diabetes management platform and mobile app. In January 2015, the company launched the OneTouch Verio blood glucose monitoring system that helps people with diabetes to measure their blood glucose level.
KEY MARKET BENEFITS:
KEY MARKET SEGMENTS:
The Global Biosensors Market is segmented as below:
Biosensors Market By Technology
Biosensors Market By Application
Biosensors Market By Product Type
Biosensors Market By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Biosensors Market, By Technology
7.1. Biosensors Market, By Technology Type, 2020-2030
7.1.1. Thermal
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Electrochemical
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Piezoelectric
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Optical
7.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Biosensors Market, By Application Type
8.1. Biosensors Market, By Application Type, 2020-2030
8.1.1. Medical
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Food Toxicity
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Bioreactor
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Agriculture
8.1.4.1. Market Revenue and Forecast (2016-2030)
8.1.5. Environment
8.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Biosensors Market, By End-use
9.1. Biosensors Market, By End-use, 2020-2030
9.1.1. Home Healthcare Diagnostics
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. PoC Testing
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Food Industry
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Research Laboratories
9.1.4.1. Market Revenue and Forecast (2016-2030)
9.1.5. Security and Bio-defense
9.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Biosensors Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Technology (2016-2030)
10.1.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.1.3. Market Revenue and Forecast, By End-use (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.1.4.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.1.4.3. Market Revenue and Forecast, By End-use (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.1.5.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.1.5.3. Market Revenue and Forecast, By End-use (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.2.3. Market Revenue and Forecast, By End-use (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.4.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.2.4.3. Market Revenue and Forecast, By End-use (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.5.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.2.5.3. Market Revenue and Forecast, By End-use (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.6.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.2.6.3. Market Revenue and Forecast, By End-use (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.7.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.2.7.3. Market Revenue and Forecast, By End-use (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.3.3. Market Revenue and Forecast, By End-use (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.4.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.3.4.3. Market Revenue and Forecast, By End-use (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.5.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.3.5.3. Market Revenue and Forecast, By End-use (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.6.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.3.6.3. Market Revenue and Forecast, By End-use (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.7.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.3.7.3. Market Revenue and Forecast, By End-use (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.4.3. Market Revenue and Forecast, By End-use (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.4.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.4.4.3. Market Revenue and Forecast, By End-use (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.5.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.4.5.3. Market Revenue and Forecast, By End-use (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.6.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.4.6.3. Market Revenue and Forecast, By End-use (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.7.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.4.7.3. Market Revenue and Forecast, By End-use (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.5.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.5.3. Market Revenue and Forecast, By End-use (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.5.4.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.5.4.3. Market Revenue and Forecast, By End-use (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.5.5.2. Market Revenue and Forecast, By Application Type (2016-2030)
10.5.5.3. Market Revenue and Forecast, By End-use (2016-2030)
Chapter 11. Company Profiles
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Biosensor BV
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Bayer AG
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Cranfield Biotechnology Centre
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. DuPont Biosensor Materials
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Ercon, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Johnson and Johnson
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers